Actionable news
All posts from Actionable news
Actionable news in GSK: GLAXOSMITHKLINE PLC,

GlaxoSmithKline (GSK) Leads The Pack In Pre-Market Activity

Trade-Ideas LLC identified GlaxoSmithKline ( GSK) as a pre-market leader candidate. In addition to specific proprietary factors, Trade-Ideas identified GlaxoSmithKline as such a stock due to the following factors:

  • GSK has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $171.7 million.
  • GSK traded 18,740 shares today in the pre-market hours as of 7:43 AM.
  • GSK is up 4.9% today from yesterday's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in GSK with the Ticky from Trade-Ideas. See the FREE profile for GSK NOW at Trade-Ideas More details on GSK: GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The stock currently has a dividend yield of 5.8%. GSK has a PE ratio of 24. Currently there are 2 analysts that rate GlaxoSmithKline a buy, 1 analyst rates it a sell, and 4 rate it a hold. The average volume for GlaxoSmithKline has been 3.2 million shares per day over the past 30 days. GlaxoSmithKline has a market cap of...